Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling.
about
Understanding and targeting resistance mechanisms in NSCLC.Inhibitor repurposing reveals ALK, LTK, FGFR, RET and TRK kinases as the targets of AZD1480.Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naïve LesionsCombined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusions
P2860
Resistance to RET-Inhibition in RET-Rearranged NSCLC Is Mediated By Reactivation of RAS/MAPK Signaling.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Resistance to RET-Inhibition i ...... ivation of RAS/MAPK Signaling.
@en
Resistance to RET-Inhibition i ...... ivation of RAS/MAPK Signaling.
@nl
type
label
Resistance to RET-Inhibition i ...... ivation of RAS/MAPK Signaling.
@en
Resistance to RET-Inhibition i ...... ivation of RAS/MAPK Signaling.
@nl
prefLabel
Resistance to RET-Inhibition i ...... ivation of RAS/MAPK Signaling.
@en
Resistance to RET-Inhibition i ...... ivation of RAS/MAPK Signaling.
@nl
P2093
P2860
P1476
Resistance to RET-Inhibition i ...... ivation of RAS/MAPK Signaling.
@en
P2093
Andrea Doak
Katie M Mishall
Laura Schubert
Marileila Varella-Garcia
Minjae Yoo
Robert C Doebele
Sarah K Nelson-Taylor
P2860
P304
P356
10.1158/1535-7163.MCT-17-0008
P577
2017-05-12T00:00:00Z